法规动态

Ahead of a national audit, the Seoul City Pharmacists Association urged the National Assembly to prioritize patient safety and strengthen oversight before expanding telemedicine drug delivery and safety‑standby medicines.

Pharmacists and civil groups in South Korea are staging protests and a nationwide rally after a petition against remote prescription drug delivery gathered 50,000 signatures.

The Korean Pharmacists Association urges the government to scrap the 7‑day limit on first‑time telemedicine prescriptions and the planned expansion of drug delivery, citing patient safety.

Health Canada alerts that counterfeit laser hair removal devices marketed as “Soprano” are being sold to clinics in Canada, posing health risks and violating regulations.

Trinity Biotech is recalling Oxalate Reagent B (Product Code 591-2, Lot 2500711) because of performance variability causing negative bias and under‑recovery of oxalate values, potentially yielding falsely low patient results.

Trinity Biotech is recalling Oxalate Reagent B (Product Code 591-2, Lot 2500711) due to performance variability that may produce falsely low oxalate results. Users should stop use and quarantine inventory.

MHRA reports ongoing fatal and serious harm from patient falls involving hoists or slings, noting an average of two deaths in recent incidents.

Data from police and health ministry show 73,313 dementia‑patient missing reports from 2022 to June 2024, while cumulative fingerprint pre‑registration remains at 50.2%.

The Guro‑gu Pharmacy Association delivered local pharmacists’ concerns to the National Assembly, warning that a full rollout of remote prescription delivery could impact community pharmacy networks and patient safety.

Health Consumer Solidarity says expanding drug delivery for telemedicine must be preceded by a thorough safety and outcome review, prioritizing public health over convenience.

GE Healthcare reports two potential safety issues affecting order summary components in certain Centricity High Acuity anesthesia systems.

Korea plans to broaden medication delivery for telemedicine patients, prompting calls to address safety risks and clarify liability among pharmacies, platforms and couriers.